Camarda Financial Advisors, LLC Gsk PLC Transaction History

Camarda Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $566 - $609	-14 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$39.4 - $42.7 $19,030 - $20,624	-483 Reduced 97.18%	14 $1,000
Q1 2019 Apr 25, 2019	BUY	$38.57 - $42.69 $19,169 - $21,216	497 New	497 $21,000
Q1 2018 Apr 30, 2018	SELL	$36.18 - $40.15 $72,360 - $80,300	-2,000 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$39.44 - $41.55 $78,880 - $83,100	2,000	2,000 $81,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Camarda Financial Advisors, LLC with notifications on news.